curcumaxan-logo-web.png

de gb

Apurano Pharmaceuticals launches CurcumaXan® curcumin spray as a prescription medicine
After 2 years of development and 2 clinical trials which tested the absorption of CurcumaXan®, the prescription drug CurcumaXan® will be available in pharmacies from 1.7.2019. What is special about CurcumaXan® is its superior bioavailability compared to curcumin infusions, alongside increased safety. The PuranoTec manufacturing process, developed and patented by Apurano, converts the active ingredient curcumin into a liquid form, optimising its availability for the human body. 

CurcumaXan® is administered via a spray onto the oral mucosa and is thus rapidly absorbed. Because CurcumaXan® is manufactured in accordance with GMP and is subject to the controls of the pharmaceutical regulatory authority, both therapist and patient can rely on its quality. Stability tests on CurcumaXan® over a period of more than 19 months provide proof of this. 

For more information about CurcumaXan®, therapists and pharmacists can access our secure area or contact our specialist advisor, Mr Wedlich, at curcumaxan@apurano.de or on the telephone number 0175/1521189. 
 
Apurano – High Tech in Life Sciences
 
Apurano Pharmaceuticals GmbH develops and produces phytopharmaceuticals using the patented manufacturing process PuranoTec®. PuranoTec® converts poorly water-soluble constituents of plants or fungi using a physical method into a form that can be optimally absorbed by the body. This process does not involve any chemical additives or other solvents. With  PuranoTec®, the entire body of the plant or fungus is converted into a liquid form, which is then sprayed onto the inside of the cheeks and under the tongue using an active spray. Products manufactured using the PuranoTec® method have a special surface finish that facilitates absorption by the body. By applying products to the oral mucosa, all components of the plant or fungus are absorbed by the body directly. Metabolisation by the liver – which is often a problem for naturopathic products – can thus be bypassed, and the active ingredients are transported to their destination. The improved intake of naturopathic products forms the basis of their efficacy.
 
For more information, please contact:


Apurano Pharmaceuticals GmbH

Dr Werner Brand
Managing Director

werner.brand@apurano.de
Tel: 08024 46869-01